De Novo Design of Integrin α5β1 Modulating Proteins for Regenerative Medicine

Xinru Wang,Jordi Guillem-Marti,Saurav Kumar,David Lee,Daniel Cabrerizo-Aguado,Rachel Werther,Kevin Alexander Estrada Alamo,Yan-Ting Zhao,Adam Nguyen,Irina Kopyeva,Buwei Huang,Jing Li,Yuxin Hao,Xinting Li,Aritza Brizuela-Velasco,Analisa N Murray,Stacey Gerben,Anindya Roy,Cole A DeForest,Timothy Springer,Hannele Ruohola-Baker,Jonathan Cooper,Melody G Campbell,Jose Maria Manero,Maria-Pau Ginebra,David Baker
DOI: https://doi.org/10.1101/2024.06.21.600123
2024-07-10
Abstract:Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins could have considerable utility in regenerative medicine and next-generation therapeutics. We use computational protein design to create de novo α5β1-specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin and RGD peptide in enhancing cell attachment and spreading, and NeoNectin-coated titanium implants outperformed fibronectin and RGD-coated implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine.
Bioengineering
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a new type of small protein that can specifically regulate integrin α5β1 for use in regenerative medicine. Specifically, the researchers aim to design a brand - new protein named NeoNectin. This protein can specifically bind to and stabilize the open conformation of integrin α5β1, thereby enhancing cell adhesion and migration and ultimately promoting tissue regeneration and bone growth. ### Main problem background: 1. **Importance of integrin α5β1**: Integrin α5β1 is one of the main receptors for the interaction between cells and the extracellular matrix (ECM), and it plays a crucial role especially in the processes of cell adhesion and migration. These processes are essential for development, wound healing, bone regeneration, and stem cell therapy, etc. 2. **Limitations of existing methods**: - **Full - length fibronectin (FN)**: Although FN is the main ligand of α5β1, due to its complex source (usually from human plasma), it is difficult to produce on a large scale and is easily degraded by proteases. - **RGD peptide**: Although the RGD peptide is easy to synthesize and is widely used in biomaterial coatings, its affinity is low, it cannot effectively promote bone formation in vivo, and it has a broad reactivity to multiple RGD - binding integrins, resulting in insufficient specificity. 3. **Research objectives**: The researchers hope to create small, stable, and easy - to - manufacture α5β1 - specific binding proteins (NeoNectin) through computational protein design methods to overcome the above challenges. These proteins can not only specifically activate α5β1 but also significantly enhance the ability of cells to adhere and spread on biomaterials. ### Solutions: - **Computational design**: Use Rosetta software for flexible backbone protein design to optimize the structure and sequence to achieve shape complementarity and extensive interaction with α5β1. - **Experimental verification**: Screen high - affinity designs through yeast surface display technology and further optimize to obtain the best NeoNectin variant. - **Functional evaluation**: Verify the function of NeoNectin and its impact on cell behavior through multiple experiments (such as fluorescence microscopy, electron microscopy, cell adhesion experiments, etc.). ### Result highlights: - The affinity of NeoNectin for α5β1 is much higher than that of FN and RGD peptide, being 680 times and 16,700 times higher respectively. - On the titanium surface and in 3D hydrogels, NeoNectin significantly enhances cell adhesion and spreading, outperforming the traditional FN and RGD peptide. - Animal model experiments show that NeoNectin - modified titanium implants perform excellently in promoting tissue integration and bone growth. In conclusion, this research provides a new tool for regenerative medicine - NeoNectin, which not only solves the limitations of existing methods but also shows broad application prospects.